Serveur d'exploration sur l'Indium - Analysis (France)

Index « Keywords » - entrée « Somatostatin (diagnostic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Somatostatin (analogs & derivatives) < Somatostatin (diagnostic use) < Somatostatin (metabolism)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]
Ident.Authors (with country if any)Title
000058 (2009) Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.
000076 (2008) Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
000085 (2007) Paraneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition.
000093 (2006) [Imaging strategy for staging and follow-up of endocrine tumors].
000106 (2006) Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases.
000110 (2005) Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
000117 (2005) Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
000130 (2003) Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors.
000135 (2002) [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
000140 (2002) Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
000142 (2001) Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis.
000154 (2000) Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
000158 (2000) 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
000162 (1999) Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy.
000165 (1999) In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.
000168 (1999) Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
000170 (1999) Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
000172 (1999) Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
000175 (1998) Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake.
000180 (1998) In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma.
000182 (1997) [Peroperative detection probes. Evaluation and perspectives in endocrinology].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Somatostatin (diagnostic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Somatostatin (diagnostic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Somatostatin (diagnostic use)
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024